Target Name: VEZT
NCBI ID: G55591
Other Name(s): VEZA_HUMAN | VEZT variant 1 | DKFZp761C241 | Vezatin | vezatin, adherens junctions transmembrane protein | VEZATIN | Vezatin, adherens junctions transmembrane protein, transcript variant 1 | Vezatin (isoform b)

VEZA: A Potential Drug Target for Cancer and Other Diseases

VEZT (VEZA_HUMAN) is a protein that is expressed in human tissues and has been identified as a potential drug target or biomarker. The protein is derived from the VEZA gene, which is located on chromosome 1p36. VEZA is a key regulator of the androgen receptor (AR), which plays a role in the development and maintenance of male characteristics.

VEZA has been shown to be involved in the development and progression of various diseases, including cancer, and has been identified as a potential therapeutic target for these diseases. One of the main reasons for this is its role in the regulation of cell proliferation, which is critical for the development and growth of cancer.

VEZA has also been shown to be involved in the regulation of gene expression, which is another key aspect of cancer development. By regulating the expression of genes that are important for cell growth and division, VEZA can contribute to the development and progression of cancer.

In addition to its role in cancer development, VEZA has also been shown to be involved in the regulation of male development and gender identity. This is because VEZA is expressed in the primary sexual organs and is involved in the development and maintenance of male characteristics.

VEZA has also been shown to be involved in the regulation of bone development and maintenance. This is because VEZA is expressed in the bones and is involved in the development and maintenance of bone structure.

VEZA has also been shown to be involved in the regulation of fat metabolism. This is because VEZA is expressed in the fat cells and is involved in the regulation of fat metabolism.

In conclusion, VEZA is a protein that is expressed in human tissues and has been identified as a potential drug target or biomarker. Its role in the regulation of cell proliferation, gene expression, cancer development, male development and gender identity, bone development and maintenance, and fat metabolism makes it an attractive target for therapeutic intervention. Further research is needed to fully understand the role of VEZA in these processes and to develop effective treatments for the prevention and treatment of diseases associated with VEZA.

Protein Name: Vezatin, Adherens Junctions Transmembrane Protein

Functions: Plays a pivotal role in the establishment of adherens junctions and their maintenance in adult life. Required for morphogenesis of the preimplantation embryo, and for the implantation process

More Common Targets

VGF | VGLL1 | VGLL2 | VGLL3 | VGLL4 | VHL | VIL1 | VILL | VIM | VIP | VIPAS39 | VIPR1 | VIPR1-AS1 | VIPR2 | VIRMA | VIT | VKORC1 | VKORC1L1 | VLDLR | VLDLR-AS1 | VMA21 | VMAC | VMO1 | VMP1 | VN1R1 | VN1R101P | VN1R108P | VN1R10P | VN1R11P | VN1R12P | VN1R17P | VN1R18P | VN1R2 | VN1R4 | VN1R46P | VN1R5 | VN1R82P | VN1R91P | VN1R96P | VN2R11P | VN2R1P | VN2R3P | VNN1 | VNN2 | VNN3P | Voltage-dependent anion channels (Porins) | Voltage-dependent calcium channel gamma subunit | Voltage-gated K(v) channel | Voltage-Gated Sodium Channel Complex | Volume-Regulated Anion Channel (VRAC) | VOPP1 | VOR Complex | VPREB1 | VPREB3 | VPS11 | VPS13A | VPS13A-AS1 | VPS13B | VPS13C | VPS13C-DT | VPS13D | VPS16 | VPS18 | VPS25 | VPS26A | VPS26AP1 | VPS26B | VPS26C | VPS28 | VPS29 | VPS33A | VPS33B | VPS35 | VPS35L | VPS36 | VPS37A | VPS37B | VPS37C | VPS37D | VPS39 | VPS41 | VPS45 | VPS4A | VPS4B | VPS50 | VPS51 | VPS51P8 | VPS52 | VPS53 | VPS54 | VPS72 | VPS8 | VPS9D1 | VPS9D1-AS1 | VRK1 | VRK2 | VRK3 | VRTN | VSIG1 | VSIG10